MET Amplification in Gallbladder Cancer: a Case Report on a Precision Medicine Approach with Glumetinib and Envafolimab
{{output}}
Background: Gallbladder adenocarcinoma (GBC) is an aggressive malignancy with poor prognosis and limited therapeutic options in advanced stages. Although MET amplification represents a potentially actionable molecular alteration,... ...
